Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP)

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 5, 2006, Pages 376-378

  Sutter, Florian K ^a   Kurz Levin, M M ^a   Fleischhauer, J ^a   Bosch M M ^a   Barthelmes, D ^a   Helbig, H ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

Age related macular degeneration; Combined therapy; Intravitreal triamcinolone; Photodynamic therapy; Retinal angiomatous proliferation

Indexed keywords

TRIAMCINOLONE ACETONIDE; ANTIINFLAMMATORY AGENT;

AGED; ANGIOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EXUDATE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; RETINA; RETINA MACULA DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION; VISUAL ACUITY; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HEMANGIOMATOSIS; INJECTION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; RETINA NEOVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANGIOMATOSIS; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 33745960760     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926564     Document Type: Conference Paper

References (8)

1. Gass JD, Agarwal A, Lavina AM et al. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003; 23: 741-751
2. Hartnett ME, Weiter JJ, Staurenghi G et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996; 103: 2042-2053
3. He S, Jin ML, Worpel V et al. A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch Ophthalmol 2003; 121: 1283-1288
4. Helbig H, Niederberger H, Valmaggia C et al. Simultaneous fluorescein and indocyanine green angiography for exudative macular degeneration. Klin Monatsbl Augenheilkd 2005; 222: 202-205
5. Kusserow C, Michels S, Schmidt-Erfurth U. Chorioretinal anastomosis as unfavourable prognostic factor during photodynamic therapy. Ophthalmologe 2003; 100: 197-202
6. Miller DW, Joussen AM, Holz FG. The molecular mechanisms of neovascular age-related macular degeneration. Ophthalmologe 2003; 100: 92-96
7. Slakter JS, Yannuzzi LA, Schneider U et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000; 107: 742-754
8. Yannuzzi LA, Negrao S, Iida T et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-634